MARK ADELMAN

Oppose HHS proposed pilot rebate for 340B; support extension of enhanced subsidies; support increases in NIH funding and oppose executive action to reduce direct costs and facilities and stopping committees from meeting; support increases to GME/CHGME to address physician shortages; oppose efforts to cut state directed payments in HR1; oppose efforts to reduce FMAP, impose work requirements in HR1, cut Medicaid financing to states in HR1; support reductions in medicare advantage prior authorization requirements; support loan forgiveness programs for healthcare workers; support clarity in statutory language protecting use of contract pharmacies.

support increases in NIH funding and oppose executive action to reduce direct costs and facilities and stopping committees from meeting; support increases to GME/CHGME to address physician shortages; oppose efforts to cut state directed payments; oppose efforts to reduce FMAP, impose work requirements, cut Medicaid financing to states; support reductions in medicare advantage prior authorization requirements; support loan forgiveness programs for healthcare workers; oppose imposition of rebates for 340B and support clarity in statutory language protecting use of contract pharmacies.

support increases in NIH funding and oppose executive action to reduce direct costs and facilities and stopping committees from meeting; support increases to GME/CHGME to address physician shortages; oppose efforts to cut state directed payments; oppose efforts to reduce FMAP, impose work requirements, cut Medicaid financing to states; support reductions in medicare advantage prior authorization requirements; support loan forgiveness programs for healthcare workers; oppose imposition of rebates for 340B and support clarity in statutory language protecting use of contract pharmacies.

oppose market basket increase in IPPS rule, support proposed rule on medicare aco payment incorporating catheter billing fraud for incentive payments, support increase in CHGME and GME funding and training slots, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives. Seek relief on ACO/Catheter fraud issue. oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, support employee retention credit timeframes, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules, support 340B contract pharmacy 340B PATIENTS Act.

oppose market basket increase in IPPS rule, oppose medicare aco payment without incorporating catheter billing fraud for incentive payments, support increase in CHGME and GME funding and training slots, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives. Seek relief on ACO/Catheter fraud issue. oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, support employee retention credit timeframes, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules, support 340B contract pharmacy 340B PATIENTS Act.

oppose market basket increase in IPPS rule, oppose medicare aco payment without incorporating catheter billing fraud for incentive payments, support increase in CHGME and GME funding and training slots, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives. oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, support employee retention credit timeframes, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules, support 340B contract pharmacy 340B PATIENTS Act.

oppose DEA proposed rules on prescription drugs for behavioral health, support increase in CHGME and GME funding and training slots, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives (e.g., HR2389). oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, support employee retention credit timeframes, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules, support 3.021 (pulmonary rehab telehealth).

oppose DEA proposed rules on prescription drugs for behavioral health, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives (e.g., HR2389). oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, support employee retention credit timeframes, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules, support 3.021 (pulmonary rehab telehealth).

oppose DEA proposed rules on prescription drugs for behavioral health, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives (e.g., HR2389). oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, investigate nursing contract companies for pandemic rates, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules.

oppose DEA proposed rules on prescription drugs for behavioral health, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives (e.g., HR2389). oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, investigate nursing contract companies for pandemic rates, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules.

oppose DEA proposed rules on prescription drugs for behavioral health, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives (e.g., HR2389). oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, investigate nursing contract companies for pandemic rates, and provide targeted support for improving hospital discharges.

support provisions in continuing resolution to increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME in appropriations, support increases to behavioral health reimbursements and programs, support congressional action/federal regulation re: nurse staffing agencies and workforce development, continue FMAP increases for states due to pandemic, support appropriations increase for NIH.

support provisions in continuing resolution to increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME in appropriations, seek $16M in senate appropriations for research renovations, support increases to behavioral health reimbursements and programs, support congressional action/federal regulation re: nurse staffing agencies and workforce development, continue FMAP increases for states due to pandemic.

support provisions in reconciliation to increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME in appropriations, seek $16M in senate appropriations for research renovations, support increases to behavioral health reimbursements and programs, support congressional action/federal regulation re: nurse staffing agencies and workforce development, seek support for merger with CNE.

support provisions American rescue plan to increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME in appropriations, seek $16M in senate appropriations for research renovations, support increases to behavioral health reimbursements and programs, support congressional action/federal regulation re: nurse staffing agencies and workforce development, seek support for merger with CNE.

support provisions American rescue plan to increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME in reconciliation, support aligning CMMI programs with payment accounting, support increases to behavioral health reimbursements and programs, support congressional action/federal regulation re: nurse staffing agencies.

support provisions American rescue plan to increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME in reconciliation, support aligning CMMI programs with payment accounting, support increases to behavioral health reimbursements and programs.

support provisions in HR 1319, American rescue plan, to codify imputed rural floor for all urban states, increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME, support FEMA cost share to 100%, support aligning CMMI programs with payment accounting, support increases to behavioral health reimbursements and programs.

support provisions in HR 1319, American rescue plan, to codify imputed rural floor for all urban states, increase funding for hospitals dealing with pandemic, delay medicare sequester and DSH cuts, support S.834, resident physician shortage act, support increases to CHGME and GME, support FEMA cost share to 100%, support aligning CMMI programs with payment accounting, support increases to behavioral health reimbursements and programs.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor and work for legislative fix on impact of imputed rural floor. oppose cuts to 340B drug pricing program. support emergency hospital funding for covid19 related expenses and criteria for funding hospital including stimulus 4 legislation and the omnibus appropriations legislation. Oppose new guidance on reporting on provider relief funds.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor and work for legislative fix on impact of imputed rural floor. oppose cuts to 340B drug pricing program. support opioid workforce act of 2019 s2892/HR3414. support emergency hospital funding for covid19 related expenses and criteria for funding hospital including stimulus 1, stimulus 2, stimulus 3 and stimulus 4 legislation. Oppose new guidance on reporting on provider relief funds.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor and work for legislative fix on impact of imputed rural floor. oppose cuts to 340B drug pricing program. support opioid workforce act of 2019 s2892/HR3414. support emergency hospital funding for covid19 related expenses and criteria for funding hospital including stimulus 1, stimulus 2 and stimulus 3 legislation.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor and work for legislative fix on impact of imputed rural floor. oppose cuts to 340B drug pricing program. support opioid workforce act of 2019 s2892/HR3414. support emergency hospital funding for covid19 related expenses and criteria for funding hospitals.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor and work for legislative fix on impact of imputed rural floor. oppose cuts to 340B drug pricing program. support opioid workforce act of 2019 s2892/HR3414. support changes to ACO MSSPs re incentive payments and baseline calculations

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor and oppose further changes to wage index. oppose cuts to 340B drug pricing program.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor. oppose cuts to 340B drug pricing program.

opposition to DSH cuts, support increase to NIH funding and CHGME/GME funding, obtain repeal of the repeal of the imputed rural floor. oppose cuts to 340B drug pricing program.

Oppose provisions of tax legislation re: bonds, executive pay and hospital rate cuts; Repeal DSH cuts; support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule and support legislation reversing the repeal of rural floor; support change to CMS MSSP accounting for CMMI funding in ACO

support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule and support legislation reversing the repeal of rural floor; support change to CMS MSSP accounting for CMMI funding in ACO

Support repeal DSH cuts; support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

Support repeal DSH cuts; support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

Oppose provisions of tax legislation re: bonds, executive pay and hospital rate cuts; Repeal DSH cuts; support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

oppose repeal of ACA if block granting and per capita caps reduce number of insured; Repeal DSH cuts; support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

oppose repeal of ACA if block granting and per capita caps reduce number of insured; Repeal DSH cuts; support GME, CHGME and CHIP funding/reauthorization; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

Repeal cuts to DSH cuts; support socioeconomic factors as part of HAC penalties; support GME, CHGME and CHIP funding; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals, including potential cuts in American Health Care Act legislation; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

Repeal cuts to DSH cuts; support socioeconomic factors as part of HAC penalties; support GME, CHGME and CHIP funding; support increase to NIH funding; oppose Medicaid/Medicare cuts to hospitals, including potential cuts in American Health Care Act legislation; oppose weakening of 340B program; oppose elimination of imputed rural floor of wage index in CMS' IPPS rule; support increased appropriations for trauma units.

Delay cuts to Medicare DSH payments; support ACEKids legislation (S.298 and HR546); supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status; supporting GME, CHGME and CHiP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation; support appropriations for trauma units; and oppose HRSA Mega-Guidance regulations re: 340B program.

Delay cuts to Medicare DSH payments; support ACEKids legislation (S.298 and HR546); supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation; support appropriations for trauma units; and oppose HRSA Mega-Guidance regulations re: 340B program.

Delay cuts to Medicare DSH payments; support ACEKids legislation (S.298 and HR546); supporting use of best possible data for calculating UCC for DSH; supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status; encourage need for more flexibility under meaningful use standards and exemptions; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation; support appropriations for trauma units; and oppose HRSA Mega-Guidance regulations re: 340B program.

Delay cuts to Medicare DSH payments; support ACEKids legislation (S.298 and HR546); supporting use of best possible data for calculating UCC for DSH; supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status; encourage need for more flexibility under meaningful use standards and exemptions; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation; support appropriations for trauma units; and oppose HRSA Mega-Guidance regulations re: 340B program.

Delay cuts to Medicare DSH payments; supporting use of best possible data for calculating UCC for DSH; supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status; encourage need for more flexibility under meaningful use standards and exemptions; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation; support appropriations for trauma units; and oppose HRSA Mega-Guidance regulations re: 340B program.

Delay cuts to Medicare DSH payments; supporting use of best possible data for calculating UCC for DSH; supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status; encourage need for more flexibility under meaningful use standards and exemptions; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation; oppose HRSA Mega-Guidance regulations re: 340B program.

Delay cuts to Medicare DSH payments; supporting use of best possible data for calculating UCC for DSH; supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status and support legislation requiring CMS to apply that risk adjustment, s.688; encourage need for more flexibility under meaningful use standards and exemptions; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-fors in legislation.

Delay cuts to Medicare DSH payments; supporting use of best possible data for calculating UCC for DSH; supporting applying risk adjustments to Medicare readmissions reduction program that acknowledges patients' socie-economic status and support legislation requiring CMS to apply that risk adjustment, s.688; encourage need for more flexibility under meaningful use standards and exemptions; supporting GME, CHGME and CHIP funding; oppose further Medicare/Medicaid cuts to hospitals; support full funding for NIH; oppose hospital funding cuts as pay-for in SGR legislation, HR2.

delay further cuts in Medicare disproportionate share (DSH) payments; supporting the use of best possible data for calculating uncompensated care for the Medicare DSH formula; supporting applying risk adjustments to the Medicare readmissions reductions program that acknowledges patients socio-economic status and supporting legislation requiring CMS to apply that risk adjustment; encourage the need for more flexibility under meaningful use standards and exemptions; support continued funding for GME and CHiP; and oppose further Medicare and Medicaid cuts to hospitals.

oppose 2 midnight rule, support CHGME reauthorization, support GME and NIH full funding, oppose Medicaid DSH cuts, seek changes to SGR and meaningful use.

support of Medicaid DSH delay, support NIH and GME funding and trauma care reauthorization, opposition to DSH and 2 midnight inclusion in IPPS proposed rule, support senate legislation for hospital readmission inclusion of other factors, seek congressional support for 2 COBRE grants sought by Lifespan.

Support 340B program and oppose rollback or shrinking of program; oppose Medicaid and Medicare DSH cuts in current statute; support NIH funding at or above current levels; support funding for GME, support senate legislation for hospital readmission inclusion of other factors; support more flexibility in meaningful use reporting.

Support of Medicaid DSH delay, support NIH and GME Funding and trauma care reauthorization, opposition to DSH and 2 midnight inclusion in IPPS proposed rule, support senate legislation for hospital readmission inclusion of other factors, seek congressional support for 2 COBRE grants sought by Lifespan

opposition to 2 Midnight Rule, support of CHGME Reauthorization, support GME and NIH funding, opposition to Medicaid DSH cuts, concerns with SGR patch provisions including ICD-10 and possible hospital funding issues and clarification for exemption to meaningful use adjustments

2 Midnight rule, CHGME Reauth, GME and NIH funding, Medicaid DSH cuts, SGR and meaningful use

Federal Funding for Hospitals and health care implications and costs for legislation